Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452060 · ClinicalTrials.gov registry record · Phase 2
Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy
A Phase 2 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT02452060 is a Phase 2 study that has completed, run by NYU Langone Health. The registered enrollment target is 90 participants.
The verdict
NCT02452060, a Phase 2 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.
Interventions
- DRUG Ketamine
- OTHER Placebo Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-04-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452060
The ClinicalTrials.gov registry entry for NCT02452060 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02452060 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452060 about?
NCT02452060 is a clinical study titled "Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy". This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmi...
What is the current status of trial NCT02452060?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2014-10. Estimated completion is 2017-04-13.
What interventions are being tested in trial NCT02452060?
The interventions under investigation include: Ketamine (DRUG), Placebo Comparator (OTHER).
Who is sponsoring clinical trial NCT02452060?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.